Recent Updates
Recently added Catalysts
IBRX Positive Sentiment

ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium

Thursday, October 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ImmunityBio, Inc. has announced that Dr. Patrick Soon-Shiong will participate in a virtual fireside chat at the Piper Sandler Virtual Oncology Symposium scheduled for October 15-16, 2026. This event aims to focus on advancements in oncology and immunotherapy. Dr. Soon-Shiong's role emphasizes the company's commitment to leadership in the field.

Market Sentiment Analysis

POSITIVE FACTORS

  • ImmunityBio is participating in a notable oncology symposium.
  • Dr. Patrick Soon-Shiong's involvement highlights the company's leadership.
  • The event provides a platform for discussing advancements in immunotherapy.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
7%
average across 3 past catalysts
Cash runway
~14 mo
Low dilution risk
Lead asset
Nogapendekin alfa inbakicept
Phase 3 · NSCLC Stage IV

Full Press Release Details

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Patrick Soon-Shiong, its Founder, Executive Chairman and Global Chief Scientific and Medical Officer, will participate virtually in a fireside chat at the Piper Sandler Virtual Oncology Symposium, taking place October 15-16, 2026. Details of the event are provided below: Piper Sandler Virtual Oncology Symposium – Fireside Chat Participant: Patrick Soon-Shion

Frequently Asked Questions

What is the Piper Sandler Virtual Oncology Symposium?

The Piper Sandler Virtual Oncology Symposium is an event focusing on advancements in oncology.

Who will represent ImmunityBio at the symposium?

Dr. Patrick Soon-Shiong will represent ImmunityBio during the fireside chat.

When is the symposium scheduled to take place?

The symposium is scheduled for October 15-16, 2026.

What is Dr. Soon-Shiong's role at ImmunityBio?

Dr. Patrick Soon-Shiong is the Founder, Executive Chairman, and Global Chief Scientific and Medical Officer.

ShareAdd on Google
Tags: IBRX ImmunityBio Piper Sandler oncology symposium immunotherapy Dr. Patrick Soon-Shiong
Last updated: Oct 8, 2026

Biotech snapshot

Cash runway
$357M liquidity · $22M/mo burn
~14 mo
Low dilution risk
Lead asset
Nogapendekin alfa inbakiceptPhase 3
NSCLC Stage IV →

Catalyst track record

+48%
best trade around IBRX's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for IBRX.

See every catalyst's timing & PoA →